ASH2025 Update on Management of Anemia in Patients with Myelofibrosis
Revisiting the Safety Record of IL-17 Inhibitors: A Guide for Dermatologists
The Evolving Science of Tyrosine Kinase 2 (TYK2) Inhibitors to Improve Outcomes in Patients with Psoriatic Arthritis
Novel Therapeutic Approaches to Multiple Sclerosis: BTK and Second-Generation Anti-CD40 Therapeutics
Updating the Efficacy and Safety Experience of IL-17 Inhibitors
Endogenous Hypercortisolism: Beyond Weight Gain and Moon Facies
Update on Long-Acting Nebulizers for Guideline-Based Maintenance Treatments for Patients with COPD
Late Breaking Clinical Trial Data from AHA 2025 on Approved and Emerging Lipid Lowering Therapies: Highlights Selected by the Experts
Late Breaking Clinical Trial Data from AHA 2025 on Approved and Emerging Lipid Lowering Therapies: Highlights Selected by the Experts
Late-Breaking Clinical Trial Data from AHA 2025 on Approved and Emerging Lipid-Lowering Therapies: Highlights Selected by the Experts